News
Important Only
Soccer-10-man Rangers hold Bilbao to Europa League goalless draw
GLASGOW, Scotland, April 10 (Reuters) - Rangers held Athletic Bilbao to a nail-biting goalless draw at home in the first leg of their Europa League quarter-final on Thursday, despite being reduced to 10 men early on.Bilbao failed to capitalise on their numerical advantage after Rangers defender Robi...Reuters
Thu, Apr 10
Soccer-Cherki stoppage-time strike earns Lyon dramatic draw with Manchester Utd
By Peter Hall LYON, France, April 10 (Reuters) - A stoppage-time finish from Rayan Cherki earned Olympique Lyonnais a dramatic 2-2 draw with Manchester United in the first leg of their Europa League quarter-final on Thursday, with visiting goalkeeper Andre Onana's errors costing his side dear...Reuters
Thu, Apr 10
Europeans sidelined in US-Iran nuclear talks despite holding key card
US to hold talks with Iran on SaturdayEuropeans weigh triggering UN sanctions mechanismCoordination difficult with WashingtonEuropeans have held several rounds of talks with IranBy John Irish PARIS, April 10 (Reuters) - Washington's decision not to coordinate with European nations about its n...Reuters
Thu, Apr 10
US House drops probe for data from university over pro-Palestinian protestor cases
By Karen Sloan April 10 (Reuters) - A U.S. House of Representatives committee on Thursday dropped its probe for information from Northwestern University over its law school's representation of pro-Palestinian protestors.A lawyer for the Republican-led Committee on Education and the Workforce,...Reuters
Thu, Apr 10
Argenx Announces FDA Approval Of Vyvgart Hytrulo Prefilled Syringe For Self-Injection In Generalized Myasthenia Gravis And Chronic Inflammatory Demyelinating Polyneuropathy
April 10 (Reuters) - argenx SE ARGX.BR:ARGENX ANNOUNCES FDA APPROVAL OF VYVGART HYTRULO PREFILLED SYRINGE FOR SELF-INJECTION IN GENERALIZED MYASTHENIA GRAVIS AND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHYReuters
Thu, Apr 10
US FDA approves syringe version of Argenx's immune disorder drug
April 10 (Reuters) - The U.S. Food and Drug Administration has approved a pre-filled syringe version of Netherlands-based Argenx SE's ARGX.BR blockbuster immune disorder drug, Vyvgart, giving patients the more convenient option of at-home self administration, the company said on Thursday.Reuters
Thu, Apr 10
ANALYSIS-Europeans sidelined in US-Iran nuclear talks despite holding key card
US to hold talks with Iran on SaturdayEuropeans weigh triggering UN sanctions mechanismCoordination difficult with WashingtonEuropeans have held several rounds of talks with IranBy John Irish PARIS, April 10 (Reuters) - Washington's decision not to coordinate with European nations about its n...Reuters
Thu, Apr 10
EU leaders plan Beijing trip in July for summit with China's Xi, SCMP reports
April 11 (Reuters) - European Union leaders are planning to travel to Beijing for a summit with Chinese President Xi Jinping in late July, the South China Morning Post reported on Friday citing five people familiar with the arrangement.Reuters
Thu, Apr 10
MSP Recovery Enters Term Sheet To Reduce Costs And Deleverage - SEC Filing
April 10 (Reuters) - MSP Recovery Inc MSPR.O:MSP RECOVERY INC - ENTERS TERM SHEET TO REDUCE COSTS AND DELEVERAGE - SEC FILINGMSP RECOVERY INC - TO ESTABLISH NEW SUBSIDIARY FOR RECOVERY EFFORTS - SEC FILINGMSP RECOVERY INC - NEW SERVICER TO RECEIVE UP TO $25 MILLION LINE OF CREDIT - SEC FILINGSource ...Reuters
Thu, Apr 10
EXCLUSIVE-US NIH reverses conference travel ban for scientists
By Ahmed Aboulenein, Julie Steenhuysen and Michael Erman WASHINGTON, April 10 (Reuters) - The U.S. National Institutes of Health has reversed a ban on scientists traveling for conferences and meetings, a Department of Health and Human Services spokesperson told Reuters on Thursday.Researchers at ...Reuters
Thu, Apr 10
EMX Royalty Corp Receives $6.85 Million Early Payment From Abrasilver & Repays $10 Million Of Long-Term Debt
April 10 (Reuters) - EMX Royalty Corp EMX.V:EMX ROYALTY CORP: RECEIVES $6.85 MILLION EARLY PAYMENT FROM ABRASILVER & REPAYS $10 MILLION OF LONG-TERM DEBTSource text: [ID:n0001062993-25-007302]Reuters
Thu, Apr 10
Reborn Coffee Says Selling Securityholders To Resell Up To 6.7 Million Shares Of Common Stock - SEC Filing
April 10 (Reuters) - Reborn Coffee Inc REBN.O:REBORN COFFEE INC - SELLING SECURITYHOLDERS TO RESELL UP TO 6.7 MILLION SHARES OF COMMON STOCK - SEC FILINGSource text: [ID:n0001213900-25-030723]Reuters
Thu, Apr 10
